Patents by Inventor Kenneth P. Spina

Kenneth P. Spina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic erythromycin derivatives
    Patent number: 6274715
    Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of the formula: wherein A, B, D and E, R1, R2, and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of bacterial infections with such compositions, and processes for the preparation of the compounds.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: August 14, 2001
    Assignee: Abbott Laboratories
    Inventors: Yat Sun Or, Ly Tam Phan, Daniel T. Chu, Kenneth P. Spina, Robert Hallas, Richard L. Elliott, Michael Tufano
  • Angiotensin II receptor antagonists
    Patent number: 5326776
    Abstract: Compounds are disclosed having the formula: ##STR1## wherein the substituents are defined herein. The compounds of the invention are angiotensin II receptor antagonists.
    Type: Grant
    Filed: February 24, 1993
    Date of Patent: July 5, 1994
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Biswanath De, Thomas M. Zydowsky, Daniel J. Kerkman, John F. DeBernardis, Saul H. Rosenberg, Kazumi Shiosaki, Fatima Z. Basha, Kenneth P. Spina, Thomas W. von Geldern, Steven Boyd, Diane M. Yamamoto, Anthony K. L. Fung
  • Peptidyl aminodiol renin inhibitors
    Patent number: 5063208
    Abstract: A renin inhibiting compound having an aminodiol functional group is useful for treating hypertension, congestive heart failure and glaucoma and inhibits retroviral protease.
    Type: Grant
    Filed: June 29, 1990
    Date of Patent: November 5, 1991
    Assignee: Abbott Laboratories
    Inventors: Saul H. Rosenberg, Kenneth P. Spina, Steven R. Crowley